Novel chromenes and benzochromenes bearing arylazo moiety: molecular docking, in-silico admet, in-vitro antimicrobial and anticancer screening
作者:Tarek H. Afifi、Sayed M. Riyadh、Anwar A. Deawaly、Arshi Naqvi
DOI:10.1007/s00044-019-02387-5
日期:2019.9
liver carcinoma (HEPG-2)], exhibiting promising anticancer activity in comparison to Vinblastine, Colchicine and Doxorubicin as standard drugs. The data suggests that some of the new derivatives of chromene scaffold which emerged promising in the in-silico molecular docking studies displayed good in-vitro antimicrobial and anticancer activities and could be exploited as leads for further optimization
通过多组分反应,利用偶氮染料,丙二腈和芳醛作为起始原料,合成了苯并色烯9a – e和色烯10a – e的新型衍生物。通过IR,1 H-NMR,13阐明了新合成的化合物的结构。13 C-NMR和质谱数据。探索了新合成的化合物的硅内ADMET性能。对接研究证实了所检查化合物在所需蛋白质(即GlcN-6-P合酶和PI3K)上的得分和结合亲和力方面的良好对接结果。体外研究包括通过良好扩散方法对合成的化合物评估了对两种类型的Gm + ve和两种Gm -ve的抗菌活性以及对四种真菌的抗真菌活性。此外,测试了针对三种人类癌细胞系[人类结肠癌(HCT-116),人类乳腺腺癌(MCF-7)和肝癌(HEPG-2)]的抗癌活性,与长春花碱相比,它们显示出有希望的抗癌活性,秋水仙碱和阿霉素为标准药物。